Abstract
THE T-cell antigen receptor (TCR) regulates two signal transduction pathways: the phosphatidylinositol (Ptdlns)1 and tyrosine kinase pathways2. Stimulation of T cells with antigen or anti-TCR monoclonal antibodies induces an increase in inositol phosphates and diacylglycerol1,3 the second messengers responsible for the mobilization of cytoplasmic free calcium and activation of protein kinase C4. The TCR also activates a tyrosine kinase that is not intrinsic to the TCR2. The relationship between these two signal transduction pathways and their contribution to later T-cell responses is unclear. Studies using variants of a murine hybridoma suggested that the Ptdlns pathway might not be necessary for or be involved in regulating interleukin-2 (IL-2) production5. To address the relationship between later T-cell responses and the early biochemical signals, we investigated the ability of a heterologous receptor with defined signal transduction function to induce T-cell activation. The human muscarinic subtype-1 receptor (HMI)6, which elicits Ptdlns metabolism in neuronal cells through a G protein-coupled mechanism7, also functionally activates this pathway when expressed in the T-cell line Jurkat-derived host, J-HM1-2.2 (ref. 8). We show here that stimulation of HM1 alone induced IL-2 production and IL-2 receptor a chain expression. HM1 does not induce the tyrosine kinase pathway, suggesting that this pathway does not directly influence later T cell-activation responses. Instead, our studies indicate that activation of the Ptdlns pathway is probably sufficient to induce later T-cell responses.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Imboden, J. B. & Stobo, J. D. J. exp. Med. 161, 446–456 (1985).
Samelson, L. E., Patel, M. D., Weissman, A. M., Harford, J. B. & Klausner, R. D. Cell 46, 1083–1090 (1986).
Weiss, A. & Imboden, J. B. Adv. Immun. 41, 1–38 (1987).
Berridge, M. J. A. Rev. Biochem. 56, 159–193 (1987).
Sussman, J. J. et al. Nature 334, 625–628 (1988).
Nathanson, N. M. A. Rev. Neurosci. 10, 195–236 (1987).
Peralta, E. G. et al. EMBO J. 6, 3923–3929 (1987).
Goldsmith, M. A., Desai, D. M., Schultz, T. & Weiss, A. J. biol. Chem. 264, 17190–17197 (1989).
Meuer, S. C. et al. J. exp. Med. 157, 705–719 (1983).
Minami, Y., Samelson, L. E. & Klausner, R. D. J. biol. Chem. 262, 13342–13347 (1987).
Ledbetter, J. A. et al. J. Immun. 136, 3945–3952 (1986).
Tax, W. J. M., Hermes, F. F. M., Willems, R. W., Capel, P. J. A. & Koene, R. A. P. J. Immun. 133, 1185–1189 (1984).
Manger, B., Weiss, A., Imboden, J., Laing, T. & Stobo, J. J. Immun. 139, 395–407 (1987).
Leonard, W. J., Kronke, M., Peffer, N. J., Depper, J. M. & Green, W. C. Proc. natn. Acad. Sci. U.S.A. 82, 6281–6285 (1985).
Testi, R., Phillips, J. H. & Lanier, L. L. J . Immun. 142, 1854–1860 (1989).
Weiss, A., Imboden, J., Shoback, D. & Stobo, J. Proc. natn. Acad. Sci. U.S.A. 81, 4169–4173 (1984).
Weiss, A., Shields, R., Newton, M. Manger, B. & Imboden, J. J. Immun. 304, 445–447 (1987).
Meuer, S. C. et al. Cell 36, 897–906 (1984).
Gunter, K. C. et al. Nature 326, 505–507 (1987).
Bockenstedt, L. K. et al. J. Immun. 141, 1904–1911 (1988).
Ledbetter, J. A. et al. J. Immun. 135, 2331–2336 (1985).
Weiss, A., Manger, B. & Imboden, J. J. Immun. 137, 819–825 (1986).
June, C. H., Ledbetter, J. A., Gillespie, M. M., Lindsten, T. & Thompson, C. B. Molec. Cell Biol. 7, 4472–4481 (1987).
Kazlauskas, A. & Cooper, J. A. J. Cell Biol. 106, 1395–1402 (1988).
Rossomando, A. J., Payne, M., Weber, M. J. & Sturgill, T. W. Proc. natn. Acad. Sci. U.S.A. 86, 6940–6943 (1989).
Orloff, D. G., Frank, S. J., Robey, F. A., Weissman, A. M. & Klausner, R. D. J. biol. Chem. 264, 14812–14817 (1989).
Monostori, E., Desai, D., Brown, M. H., Cantrell, D. A. & Crumpton, M. J. J. Immun. 144, 1010–1014 (1990).
Uehara, Y., Fukazawa, H., Murakami, Y. & Mizuno, S. Biochem. biophys. Res. Commun. 163, 803–809 (1989).
June, C. et al. Proc. natn. Acad. Sci. U.S.A. (in the press).
Koretzky, G. A., Picus, J., Thomas, M. L. & Weiss, A. Nature 346, 66–68 (1990).
Wahl, M. I., Nishibe, S., Suh, P.-G., Rhee, S. G. & Carpenter, G. Proc. natn. Acad. Sci. U.S.A. 86, 1568–1572 (1989).
Mosmann, T. J. immunol. Meth. 65, 55–63 (1983).
Morrison, D. K. et al. Cell 58, 649–657 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Desai, D., Newton, M., Kadlecek, T. et al. Stimulation of the phosphatidyl-inositol pathway can induce T-cell activation. Nature 348, 66–69 (1990). https://doi.org/10.1038/348066a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/348066a0
This article is cited by
-
Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals
Cancer Immunology, Immunotherapy (2018)
-
Protein kinase D1/2 is involved in the maturation of multivesicular bodies and secretion of exosomes in T and B lymphocytes
Cell Death & Differentiation (2016)
-
Piperine inhibits type II phosphatidylinositol 4-kinases: a key component in phosphoinositides turnover
Molecular and Cellular Biochemistry (2014)
-
Diacylglycerol kinase α regulates the formation and polarisation of mature multivesicular bodies involved in the secretion of Fas ligand-containing exosomes in T lymphocytes
Cell Death & Differentiation (2011)
-
The right team at the right time to go for a home run: tyrosine kinase activation by the TCR
Nature Immunology (2010)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
